Adesão - Centro de Referência e Treinamento DST/AIDS-SP

Adesao.qxd 5/9/2008 12:42 PM Page 26Martinez. Once-daily antiretroviral therapy: Spanish Consensus Statement.Journal of Antimicrobial Chemotherapy. September 8, 2005 Number 5 Vol 56:808-818.27. William Valenti. Expanding role of coformulations in the treatment of HIVinfection: impact of fixed-dose combinations. Aids Read, 2004.28. Ammassari, A.; Murri, R.; Pezzotti, P.; Trotta, M.P.; Ravasio, L.; De Longis, P.et al. Self-reported symptoms and medication side effects influence adherenceto highly active antiretroviral therapy in persons with HIV infection. Journal ofAcquired Immune Deficiency Syndromes, 28:445-449. 2001.29. Self reported symptoms after initiation of a protease inhibitor in HIVinfectedpatients and their impact on adherence to HAART. HIV clinical trails.30. Duran, S.; Saves, M.; Spire, B; Cailleton, V.; Sobel, A.; Carrieri, P.; et al. 2001.Failure to maintain long-term adherence to highly active antiretroviral therapy:the role of lipodistrophy. Aids, 15:2441-2444.31. Nemes, MIB, Carvalho, HB, Souza, MFM.. Antiretroviral Therapy Adherencein Brazil. Aids, 2004, 18 (0):S1-S6.32. New York Department of Health. Promoting adherence to HIV antiretroviraltherapy. New York: New York Department of Health & Aids Institute. 2001.Disponível na página http://www.hivguidelines.org/public_html/center/best-practices/treatment_adherence/pdf/treat_adherence_full.pdf,acessada em 17/08/0533. Ashish Atreja; Naresh Bellam; Susan R. Levy. Strategies to enhance patientadherence: making it simple. Medscape General Medicine. 2005;7(1).Disponívelem http://www.medscape.com/viewarticle/498339, acessado em 21/10/05:34. International Aids Society Recommendations: Treatment for adult HIV infection- USA Panel. JAMA 2004;292:251-65.35. Haynes RB. Determinants of compliance: The disease and the mechanicsof treatment. Baltimore MD, Johns Hopkins University Press, 1979.26